Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months

In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohasseb, Iman, Gericke, Christian A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2012
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799550/
https://www.ncbi.nlm.nih.gov/pubmed/24358835
http://dx.doi.org/10.12688/f1000research.1-53.v1
_version_ 1782287892439105536
author Mohasseb, Iman
Gericke, Christian A
author_facet Mohasseb, Iman
Gericke, Christian A
author_sort Mohasseb, Iman
collection PubMed
description In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of this paper for dual anti-platelet therapy which did not receive sufficient attention in the original publication and the accompanying editorial.
format Online
Article
Text
id pubmed-3799550
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-37995502013-12-05 Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months Mohasseb, Iman Gericke, Christian A F1000Res Correspondence In this correspondence we discuss the results of the meta-analysis by De Luca et al. (2012) in the Archives of Internal Medicine which found that late myocardial reinfarction and stent thrombosis is more common in drug-eluting stents than in bare-metal stents. We discuss the clinical implications of this paper for dual anti-platelet therapy which did not receive sufficient attention in the original publication and the accompanying editorial. F1000Research 2012-11-21 /pmc/articles/PMC3799550/ /pubmed/24358835 http://dx.doi.org/10.12688/f1000research.1-53.v1 Text en Copyright: © 2012 Mohasseb I et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/publicdomain/zero/1.0/ Data associated with the article are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).
spellingShingle Correspondence
Mohasseb, Iman
Gericke, Christian A
Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title_full Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title_fullStr Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title_full_unstemmed Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title_short Continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
title_sort continuation of dual anti-platelet therapy after drug-eluting stents in primary angioplasty beyond 12 months
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799550/
https://www.ncbi.nlm.nih.gov/pubmed/24358835
http://dx.doi.org/10.12688/f1000research.1-53.v1
work_keys_str_mv AT mohassebiman continuationofdualantiplatelettherapyafterdrugelutingstentsinprimaryangioplastybeyond12months
AT gerickechristiana continuationofdualantiplatelettherapyafterdrugelutingstentsinprimaryangioplastybeyond12months

Ejemplares similares